IMGN ImmunoGen, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

IMGN [NASD]

ImmunoGen, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	0.50%	Shs Outstand	174.35M	Perf Week	-9.37%
Market Cap	622.80M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-13.82%	Shs Float	173.22M	Perf Month	-18.51%
Income	-70.30M	PEG	-	EPS next Q	-0.18	Inst Own	80.50%	Short Float	9.35%	Perf Quarter	-17.04%
Sales	86.50M	P/S	7.20	EPS this Y	41.80%	Inst Trans	0.91%	Short Ratio	7.13	Perf Half Y	-45.96%
Book/sh	-0.14	P/B	-	EPS next Y	-8.70%	ROA	-26.60%	Target Price	6.96	Perf Year	33.64%
Cash/sh	1.30	P/C	2.84	EPS next 5Y	-	ROE	147.30%	52W Range	1.95 - 7.07	Perf YTD	-28.01%
Dividend	-	P/FCF	-	EPS past 5Y	0.10%	ROI	124.60%	52W High	-48.02%	Beta	2.27
Dividend %	-	Quick Ratio	-	Sales past 5Y	-0.80%	Gross Margin	-	52W Low	88.46%	ATR	0.24
Employees	75	Current Ratio	2.70	Sales Q/Q	-3.20%	Oper. Margin	-59.70%	RSI (14)	34.48	Volatility	4.56% 5.60%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	52.50%	Profit Margin	-81.30%	Rel Volume	0.52	Prev Close	3.83
Shortable	Yes	LT Debt/Eq	-	Earnings	Jul 31 BMO	Payout	-	Avg Volume	2.27M	Price	3.67
Recom	2.20	SMA20	-12.30%	SMA50	-16.83%	SMA200	-12.65%	Volume	1,172,441	Change	-4.05%

Dec-17-19

Reiterated

H.C. Wainwright

Buy

$5 → $9

Aug-13-19

Reiterated

H.C. Wainwright

Buy

$4 → $5

May-15-19

Downgrade

Guggenheim

Buy → Neutral

May-06-19

Upgrade

H.C. Wainwright

Neutral → Buy

May-06-19

Upgrade

Cowen

Market Perform → Outperform

Mar-19-19

Downgrade

JP Morgan

Neutral → Underweight

Mar-05-19

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Mar-04-19

Downgrade

SVB Leerink

Outperform → Mkt Perform

Mar-04-19

Downgrade

H.C. Wainwright

Buy → Neutral

$18 → $3.50

Mar-01-19

Downgrade

Piper Jaffray

Overweight → Neutral

$13 → $2.50

Mar-01-19

Downgrade

Jefferies

Buy → Hold

Sep-07-18

Initiated

Piper Jaffray

Overweight

Feb-08-18

Resumed

RBC Capital Mkts

Outperform

$12

Jan-31-18

Initiated

H.C. Wainwright

Buy

$18

Jul-06-17

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

$5 → $12

Apr-19-17

Upgrade

Leerink Partners

Mkt Perform → Outperform

Apr-29-16

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$18 → $7

Feb-01-16

Reiterated

RBC Capital Mkts

Outperform

$19 → $18

Nov-25-15

Upgrade

Jefferies

Hold → Buy

Sep-21-15

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Aug-04-20 11:14AM	Did Hedge Funds Make The Right Call On ImmunoGen, Inc. (IMGN) ? Insider Monkey
Aug-03-20 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
10:53AM	ImmunoGen (IMGN) Q2 Earnings and Sales Beat, Shares Down Zacks
Jul-31-20 07:03PM	Immunogen Inc (IMGN) Q2 2020 Earnings Call Transcript Motley Fool -5.95%
07:45AM	ImmunoGen (IMGN) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:34AM	Immunogen: Q2 Earnings Insights Benzinga
06:30AM	ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results Business Wire
Jul-29-20 04:30PM	ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference Business Wire
Jul-27-20 01:08PM	What Type Of Shareholders Own The Most Number of ImmunoGen, Inc. (NASDAQ:IMGN) Shares? Simply Wall St.
Jul-24-20 12:30PM	Will ImmunoGen (IMGN) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-22-20 08:00AM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jul-20-20 07:00AM	ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer Business Wire
Jul-16-20 04:01PM	ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2020 Operating Results Business Wire
Jul-14-20 05:31PM	3 Healthcare Stocks Under $5 With Triple-Digit Upside Potential TipRanks
Jun-23-20 09:42PM	Hedge Funds Have Never Been This Bullish On ImmunoGen, Inc. (IMGN) Insider Monkey
Jun-22-20 09:01AM	ImmunoGen Presents Preclinical Data on IMGN151 at Virtual AACR Annual Meeting Business Wire +6.13%
Jun-03-20 08:00AM	ImmunoGen Announces Virtual 2020 Annual Meeting of Shareholders Business Wire -7.80%
Jun-02-20 08:00AM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jun-01-20 08:00AM	ImmunoGen Appoints Stacy Coen as Senior Vice President and Chief Business Officer Business Wire +5.13%
May-31-20 11:30AM	Why Is ImmunoGen (IMGN) Up 14.7% Since Last Earnings Report? Zacks
May-29-20 08:01AM	ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status Business Wire
May-20-20 10:04PM	Edited Transcript of IMGN earnings conference call or presentation 1-May-20 12:00pm GMT Thomson Reuters StreetEvents +15.58%
04:30PM	ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference Business Wire
03:44PM	Why ImmunoGen Stock Jumped Today Motley Fool
May-19-20 04:08PM	7 Biotech Stocks Wall Street Says Will Double or More Kiplinger
May-15-20 12:01AM	ImmunoGen to Present Preclinical Data on IMGN151 at AACR Virtual Annual Meeting Business Wire +7.26%
May-13-20 05:01PM	ImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status Business Wire -5.12%
May-06-20 04:30PM	ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference Business Wire
May-05-20 07:55AM	ImmunoGen, Inc. (NASDAQ:IMGN) Just Reported, And Analysts Assigned A US$6.75 Price Target Simply Wall St. -5.07%
May-04-20 04:17PM	Why ImmunoGen Stock Jumped Today Motley Fool +15.73%
04:05PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
11:02AM	ImmunoGen (IMGN) Q1 Earnings and Sales Miss, Shares Down Zacks
09:03AM	Such Is Life: How ImmunoGen (NASDAQ:IMGN) Shareholders Saw Their Shares Drop 57% Simply Wall St.
May-01-20 01:31PM	Immunogen Inc (IMGN) Q1 2020 Earnings Call Transcript Motley Fool -8.09%
07:10AM	Immunogen: Q1 Earnings Insights Benzinga
06:30AM	ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results Business Wire
Apr-24-20 12:30PM	Will ImmunoGen (IMGN) Report Negative Earnings Next Week? What You Should Know Zacks -5.14%
Apr-16-20 04:01PM	ImmunoGen Announces Conference Call to Discuss Its First Quarter 2020 Operating Results Business Wire
Mar-15-20 11:30AM	Why Is ImmunoGen (IMGN) Down 45.5% Since Last Earnings Report? Zacks
Feb-21-20 10:17AM	Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Feb-18-20 08:35AM	Stock Market News for Feb 18, 2020 Zacks -9.71%
Feb-17-20 09:41AM	ImmunoGen (IMGN) Q4 Earnings & Sales Beat, Shares Rally Zacks
Feb-14-20 05:00PM	US Indexes Close Mostly Flat Friday With Gains for the Week GuruFocus.com +26.87%
07:45AM	ImmunoGen (IMGN) Q4 Earnings and Revenues Beat Estimates Zacks
06:30AM	ImmunoGen Reports Recent Progress and 2019 Financial Results Business Wire
Feb-07-20 12:30PM	Will ImmunoGen (IMGN) Report Negative Earnings Next Week? What You Should Know Zacks -5.11%
Feb-06-20 04:30PM	ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences Business Wire
Feb-03-20 04:30PM	ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
09:50AM	Should You Worry About ImmunoGen, Inc.'s (NASDAQ:IMGN) CEO Pay Cheque? Simply Wall St.
Jan-30-20 04:01PM	ImmunoGen Announces Conference Call to Discuss Its 2019 Operating Results Business Wire
Jan-27-20 04:01PM	ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Jan-23-20 07:24AM	The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment Benzinga
Jan-22-20 08:44PM	ImmunoGen Announces Pricing of Public Offering of Common Stock Business Wire
04:01PM	ImmunoGen Announces Proposed Public Offering of Common Stock Business Wire
Jan-03-20 10:46AM	ImmunoGen Announces Webcast of Presentation and Q&A at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-31-19 04:01PM	ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Dec-24-19 07:12AM	ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway (Revised) Zacks
Dec-19-19 12:50PM	Bed Bath & Beyond and 3 more stocks showing momentum MarketWatch +10.26%
12:05PM	4 Momentum Stocks To Watch Benzinga
09:04AM	ImmunoGen (IMGN) Looks Good: Stock Adds 7.6% in Session Zacks
Dec-18-19 08:25AM	ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway Zacks +7.58%
Dec-17-19 04:00PM	ImmunoGen shares rise on ovarian cancer study MarketWatch +18.77%
06:30AM	ImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian Cancer Business Wire
Dec-14-19 09:13PM	Hedge Funds Are Dumping ImmunoGen, Inc. (IMGN) Insider Monkey
Dec-09-19 03:01PM	ImmunoGen Presents Updated Findings from Phase 1 Study of IMGN632 at ASH Annual Meeting Business Wire
Dec-01-19 09:30AM	ImmunoGen (IMGN) Up 51.7% Since Last Earnings Report: Can It Continue? Zacks
Nov-26-19 04:30PM	ImmunoGen Announces Webcast of Presentation at the Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-18-19 09:34AM	Roche Gets CHMP Opinion for Breast Cancer & Lymphoma Drugs Zacks
Nov-10-19 12:50AM	Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-07-19 02:51PM	Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy? Insider Monkey
Nov-06-19 09:01AM	ImmunoGen to Present New Data on IMGN632 at 61st ASH Annual Meeting Business Wire -11.65%
Nov-05-19 07:29AM	How Many ImmunoGen, Inc. (NASDAQ:IMGN) Shares Do Institutions Own? Simply Wall St. +22.86%
Nov-04-19 11:54AM	ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares Rally Zacks
09:27AM	Company News for Nov 4, 2019 Zacks
Nov-01-19 07:45AM	ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue Estimates Zacks +27.73%
06:30AM	ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results Business Wire
Oct-25-19 10:31AM	ImmunoGen (IMGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-18-19 04:30PM	ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2019 Operating Results Business Wire
Sep-30-19 09:49AM	Did ImmunoGen, Inc. (NASDAQ:IMGN) Insiders Buy Up More Shares? Simply Wall St. -11.03%
Sep-29-19 06:01AM	ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin® at ESMO Business Wire
02:31AM	ImmunoGen Presents Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer at ESMO Business Wire
Sep-26-19 01:18PM	Edited Transcript of IMGN earnings conference call or presentation 2-Aug-19 12:00pm GMT Thomson Reuters StreetEvents -6.40%
Sep-17-19 06:30AM	ImmunoGen to Present Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine and Initial Data from Phase 1b FORWARD II Triplet Cohort at ESMO Business Wire -5.31%
Sep-01-19 09:30AM	ImmunoGen (IMGN) Up 18.8% Since Last Earnings Report: Can It Continue? Zacks
Aug-07-19 11:20AM	Jazz Pharma (JAZZ) Q2 Earnings and Sales Beat Estimates Zacks
Aug-06-19 06:51AM	Immunogen Inc (IMGN) Q2 2019 Earnings Call Transcript Motley Fool +12.00%
Aug-05-19 10:18AM	ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat Zacks +11.61%
Aug-02-19 03:00PM	What You'll Want to Know About ImmunoGen's Q2 Results Motley Fool
07:55AM	ImmunoGen (IMGN) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:30AM	ImmunoGen Reports Recent Progress and Second Quarter 2019 Financial Results Business Wire
06:00AM	ImmunoGen, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-19 10:30AM	Earnings Preview: ImmunoGen (IMGN) Q2 Earnings Expected to Decline Zacks +5.86%
Jul-18-19 04:30PM	ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results Business Wire
Jul-12-19 08:58AM	Will ImmunoGen Continue to Surge Higher? Zacks
Jun-28-19 02:23PM	Penny Stocks to Buy Using Technical Analysis for July 2019 Investopedia +5.85%
05:36AM	ImmunoGen axes 75% of staff to fund new clinical trial American City Business Journals
Jun-27-19 11:21AM	Heres What Hedge Funds Think About ImmunoGen, Inc. (IMGN) Insider Monkey +5.67%
06:30AM	ImmunoGen Announces Completion of Operational Review Business Wire
Jun-03-19 06:20PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN ACCESSWIRE
Jun-02-19 09:30AM	Why Is ImmunoGen (IMGN) Down 26% Since Last Earnings Report? Zacks

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; IMGN779 that is in Phase I clinical trial for the treatment of acute myeloid leukemia (AML); and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. ImmunoGen, Inc. has collaborations with Roche, Amgen/Oxford BioTherapeutics, sanofi-aventis U. S. LLC, Biotest AG, Bayer HealthCare AG, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Fusion Pharmaceuticals Inc., Debiopharm International SA, Jazz Pharmaceuticals Ireland Limited, and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FOSTER DAVID G	V.P.-Fin., Prin. Acctg. Off.	Apr 02	Sale	3.43	5,448	18,687	21,382	Apr 02 03:56 PM
Ryll Thomas	SVP, Technical Operations	Feb 24	Sale	4.99	16,790	83,782	75,624	Feb 25 08:38 AM
Berkenblit Anna	SVP & Chief Medical Officer	Feb 24	Sale	4.99	25,803	128,757	98,089	Feb 25 08:37 AM
Enyedy Mark J	Chief Executive Officer	Feb 24	Sale	4.99	55,222	275,558	433,776	Feb 25 08:38 AM
BARROWS CRAIG	Executive VP, General Counsel	Feb 24	Sale	4.99	16,492	82,295	145,275	Feb 25 08:36 AM
Wingrove Theresa	SVP of Regulatory Affairs	Feb 24	Sale	4.99	16,147	80,574	70,498	Feb 25 08:37 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience